Position in NVS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$48,531,269
+$10,977,966 QoQ
Shares Held
317,717
+16.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.39706090640412.ToString("F0")%
Shared 0.6294910250317106.ToString("F0")%
None 7.973448068564163.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $5,042,614,731 across 16 Drug Manufacturers - General names. NVS ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,489,121 | $1,097,320,733 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,291,826 | $997,423,745 | |
| 3 | ABBV |
AbbVie Inc.
|
3,732,204 | $811,717,043 | |
| 4 | LLY |
ELI LILLY & Co
|
779,157 | $716,645,230 | |
| 5 | AMGN |
Amgen Inc
|
1,555,021 | $547,134,134 | |
| 6 | PFE |
Pfizer Inc
|
9,769,180 | $274,318,571 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,202,321 | $167,567,475 | |
| 8 | AZN |
Astrazeneca PLC
|
684,404 | $134,978,154 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,531,269 | 317,717 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $37,553,303 | 272,382 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $32,925,875 | 256,752 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $29,447,176 | 243,345 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,847,414 | 231,857 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $21,544,041 | 221,396 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,192,482 | 219,027 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,435,697 | 210,743 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,088,856 | 259,370 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $25,273,798 | 250,310 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $25,636,223 | 251,681 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,845,351 | 246,213 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,523,428 | 266,559 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $23,553,812 | 259,632 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $21,645,441 | 284,771 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,592,755 | 361,916 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $32,841,752 | 374,265 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $30,237,588 | 345,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $29,692,925 | 363,083 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $29,869,417 | 327,372 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $28,559,548 | 334,108 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $37,618,925 | 398,379 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $34,613,642 | 398,041 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $33,869,487 | 387,789 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $34,410,422 | 417,349 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||